Pharmacological investigation of memory restorative effect of riluzole in mice

Indian Journal of Pharmacology

Volumn 44, Issue 3, 2012, Pages 366-371

  Rinwa, Puneet ^a   Jaggi, Amteshwar Singh ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

dementia; morris water maze; Riluzole; streptozotocin; TREK

Indexed keywords

ACETYLCHOLINESTERASE; GLUTATHIONE; RILUZOLE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMENTIA; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS;

EID: 84861902328     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.96337     Document Type: Article

References (27)

1. Fratiglioni L, Winblad B, Strauss EV. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Physiol Behav 2007;92:98-104.
2. Jimonet P, Audiau F, Barreau M, Blanchard JC, Boireau A, Bour Y. Riluzole series. Synthesis and in vivo antiglutamate activity of 6-substituted-2 benzothiazolamines and 3-substituted-2-imino-benzothiazolines. J Med Chem 1999;42:2828-43.
3. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two pore domain K+ channels are a novel target for anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004;65:443-52.
4. Cheramy A, Barbeiro L, Godeheu G, Glowinski J. Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett 1992;147:209-12.
5. Stutzmann JM, Bohme GA, Gandolfo G, Gottesmann C, Lafforgue J, Blanchard JC, et al. Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat. Eur J Pharmacol 1991;193:223-9.
6. Maclver MB, Amagasu SM, Mikulec AA, Monroe FA. Riluzole Anesthesia: Usedependent block of presynaptic glutamate fibers. Anesthesiology 1996;85:626-34.
7. Kretschmer BD, Kratzer U, Schmidt WJ. Riluzole, a glutamate release inhibitor and motor behavior. Naunyn Schmiedebergs Arch Pharmacol 1998;358:181-90.
8. Malgouris C, Bardot F, Daniel M, Pellis F, Rataud J, Uzan A, et al. Riluzole, a novel antiglutamate prevent memory loss and hippocampal neuronal damage in ischemic gerbils. J Neurosci 1989;9:3720-7.
9. McIntosh TK, Smith DH, Voddi M, Perri BR, Stutzmann JM. Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J Neurotrauma 1996;13:767-80.
10. Sakurada T, Sakurada S, Katsuyama S, Sakurada C, No KT, Terenius L. Noceceptin(1-7) antagonizes noceceptin induced hyperalgesia in mice. Br J Pharmacol 1999;128:941-4.
11. Morris RG. Developments of a water maze procedure for studying spatial learning in the rats. J Neurosci Methods 1984;11:47-60.
12. Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 2007;52:836-43.
13. Kaithwas G, Dubey K, Bhatia D, Sharma AD, Pillai KK. Reversal of sodium nitrite induced impairment of spontaneous alteration by Aloe Vera: Involvement of cholinergic system. Pharmacol Online 2007;3:428-37.
14. Ellman GL, Courtney KD, Valentino A, Featherstone RM. A new and rapid olometric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
15. Ohkawa H, Ohishi D, Yagi V. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
16. Beutler E, Duron O, Kelly BM. Improved methods for determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
17. Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998;112:1199-208.
18. Mayer G, Nitsch R, Hoyer S. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res 1990;532:95-100.
19. Feillet-Coudray C, Rock E, Coudray C, Grzelkowska K, Azais-Braesco V, Dardevet D, et al. Lipid peroxidation and antioxidant status in experimental diabetes. Clin Chim Acta 1999;284:31-43.
20. Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of selective neuronal Types to Alzheimer's disease. Ann N Y Acad Sci 2000;924:53-61.
21. Martinez JL, Rigter H. Endorphins alter acquisition and consolidation of an inhibitory avoidance response in rats. Neurosci Lett 1980;19:197-201.
22. Car H, Wioeniewski RJ, Wioeniewski K. 2R, 4R-APDC influence on hypoxiainduced impairment of learning and memory processes in passive avoidance test. Pol J Pharmacol 2004;56:527-37.
23. Saransaari P, Oja SS. Release of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under celldamaging conditions. Neurochem Res 1998;23:563-70.
24. Medhurst AD, Rennie G, Chapman CG, Meadows H, Duck-Worth MD, Kelsell RE, et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 2001;31:101-14.
25. Miller P, Kemp PJ, Lewis A, Chapman CG, Meadows HJ, Peers C. Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem-Rfpag domain K+ channels in central neuroprotection. J Physiol 2003;548:31-7.
26. Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M. The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol 2000;57:906-12.
27. Pan YP, Xu XH, Wang XL. mRNA expression alteration of two-pore potassium channels in the brain of beta-amyloid peptide 25-35-induced memory impaired rats. Yao Xue Xue Bao 2003;38:721-4.